ALPHA CAPITAL ANSTALT - 21 Jul 2025 SCHEDULE 13G/A Report for QUALIGEN THERAPEUTICS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE (QLGN)

Filing Manager: ALPHA CAPITAL ANSTALT
Reporting Manager: Alpha Capital Anstalt
Security: QUALIGEN THERAPEUTICS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE
Symbol: QLGN
Shares outstanding: 1,638,956 shares
Disclosed Ownership: 36,434 shares
Ownership: 2.2%
Form type: SCHEDULE 13G/A
Filing time: 07 Aug 2025, 09:48:48 UTC
Date of event: 21 Jul 2025
SEC: View on sec.gov

Quoteable Key Fact

"ALPHA CAPITAL ANSTALT disclosed 2.2% ownership in QUALIGEN THERAPEUTICS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE (QLGN) on 21 Jul 2025."

Quick Takeaways

ALPHA CAPITAL ANSTALT filed SCHEDULE 13G/A for QUALIGEN THERAPEUTICS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE (QLGN).
Disclosed ownership: 2.2%.
Date of event: 21 Jul 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Alpha Capital Anstalt	2.2%	36,434	36,434	0	/s/ Konrad Ackermann	Konrad Ackermann/Director